AIM
ARK Investment Management’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,851,205
| Closed | -$7.97M | – | 189 |
|
|
2024
Q2 | $7.97M | Sell |
23,851,205
-165,755,703
| -87% | -$55.4M | 0.07% | 103 |
|
|
2024
Q1 | $220M | Sell |
189,606,908
-8,999,711
| -5% | -$10.4M | 1.52% | 21 |
|
|
2023
Q4 | $336M | Buy |
198,606,619
+16,414,434
| +9% | +$27.7M | 1.99% | 18 |
|
|
2023
Q3 | $330M | Buy |
182,192,185
+12,442,658
| +7% | +$22.5M | 2.52% | 14 |
|
|
2023
Q2 | $316M | Buy |
169,749,527
+4,992,542
| +3% | +$9.29M | 2.09% | 18 |
|
|
2023
Q1 | $219M | Buy |
164,756,985
+20,372,918
| +14% | +$27.1M | 1.51% | 21 |
|
|
2022
Q4 | $244M | Buy |
144,384,067
+17,565,211
| +14% | +$29.7M | 2.11% | 17 |
|
|
2022
Q3 | $396M | Buy |
126,818,856
+39,460,799
| +45% | +$123M | 2.76% | 13 |
|
|
2022
Q2 | $269M | Buy |
87,358,057
+22,824,417
| +35% | +$70.3M | 1.59% | 18 |
|
|
2022
Q1 | $260M | Buy |
64,533,640
+21,352,820
| +49% | +$86.1M | 1.09% | 23 |
|
|
2021
Q4 | $359M | Buy |
43,180,820
+19,949,965
| +86% | +$166M | 1.08% | 27 |
|
|
2021
Q3 | $269M | Buy |
+23,230,855
| New | +$269M | 0.65% | 39 |
|